ESC 365 - A novel direct method to evaluate adherence to atorvastatin therapy in coronary prevention - Cut-off values generated in a clinical non-adherence study

EAPC Premium Access

A novel direct method to evaluate adherence to atorvastatin therapy in coronary prevention - Cut-off values generated in a clinical non-adherence study

Session: Poster Session 1 - Cardiovascular Pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Speaker: Doctor O. Kristiansen (Drammen, NO)

Event: EuroPrevent 2019

Congress Presentation

Add to my library

About the speaker

Doctor Oscar Kristiansen

Drammen Hospital, Drammen (Norway)

0 follower

13 more presentations in this session

Prognostic impact of proton pump inhibitors in patients after elective percutaneous coronary intervention with implantation of second-generation drug eluting stents

Speaker: Doctor O. Shahmatova (Moscow, RU)

The relationship of drug treatment safety parameters and adherence to pharmacotherapy in patients with cardiovascular diseases (according to the data of the outpatient registry)

Speaker: Doctor Y. Lukina (Moscow, RU)

Focus-group as a qualitative method for study of compliance in cardiovascular disease patients and their doctors

Speaker: Doctor O. Semenova (Saratov, RU)

Adherence to long-term treatment and some traits of patients and their doctors: a prospective study of treatment compliance in patients with cardiovascular diseases

Speaker: Doctor Y. Bulaeva (Saratov, RU)

The impact of anaemia and intravenous iron replacement therapy on exercise capacity in patients after cardiac surgery.

Speaker: Doctor C. Nugara (Palermo, IT)

Access the full session

Poster Session 1 - Cardiovascular Pharmacotherapy

Speakers: Doctor O. Kristiansen, Doctor O. Shahmatova, Doctor Y. Lukina, Doctor O. Semenova, Doctor Y. Bulaeva...

About the event

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources